Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a d-octapeptide derivative inhibitor

Molecular Microbiology

Volumn 85, Issue 4, 2012, Pages 747-767

  Niimi, Kyoko ^a   Harding, David R K ^c   Holmes, Ann R ^a   Lamping, Erwin ^a   Niimi, Masakazu ^a,d   Tyndall, Joel D A ^b   Cannon, Richard D ^a   Monk, Brian C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c MASSEY UNIVERSITY   (New Zealand)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; AMPHOTERICIN B; CYCLOHEXIMIDE; ENNIATIN; FLUCONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; MILBEMYCIN ALPHA11; MILBEMYCIN ALPHA20; MILBEMYCIN ALPHA25; MILBEMYCIN ALPHA26; MILBEMYCIN BETA11; MILBEMYCIN BETA9; MILBEMYCIN DERIVATIVE; OCTAPEPTIDE; PROTEIN CACDR1; PROTEIN CAERG11; PROTEIN CAMDR1; RC1; RC21; RC21V3; RHODAMINE 123; RHODAMINE 6G; TACROLIMUS; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; VORICONAZOLE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CACDR1 GENE; CACDR2 GENE; CANDIDA ALBICANS; CHEMOSENSITIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGAL GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SACCHAROMYCES CEREVISIAE; THRUSH; TOXICITY TESTING;

CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; ENZYME INHIBITORS; FUNGAL PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; SUPPRESSION, GENETIC;

CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 84864809458     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2012.08140.x     Document Type: Article

References (49)

1. Alani, E., Cao, L., and Kleckner, N. (1987) A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116: 541-545.
2. Albertson, G.D., Niimi, M., Cannon, R.D., and Jenkinson, H.F. (1996) Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 40: 2835-2841.
3. Aller, S.G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., etal. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-1722.
4. Balzi, E., and Goffeau, A. (1994) Genetics and biochemistry of yeast multidrug resistance. Biochim Biophys Acta 1187: 152-162.
5. Balzi, E., and Goffeau, A. (1995) Yeast multidrug resistance: the PDR network. J Bioenerg Biomembr 27: 71-76.
6. Cannon, R.D., Lamping, E., Holmes, A.R., Niimi, K., Baret, P.V., Keniya, M.V., etal. (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22: 291-321.
7. Dawson, R.J., and Locher, K.P. (2006) Structure of a bacterial multidrug ABC transporter. Nature 443: 180-185.
8. Dawson, R.J., and Locher, K.P. (2007) Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett 581: 935-938.
9. Dawson, R.J., Hollenstein, K., and Locher, K. (2007) Uptake or extrusion: crystal structures of full ABC transporters suggest a common mechanism. Mol Microbiol 65: 250-257.
10. Decottignies, A., Grant, A.M., Nichols, J.W., de Wet, H., McIntosh, D.B., and Goffeau, A. (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 273: 12612-12622.
11. Egner, R., Rosenthal, F.E., Kralli, A., Sanglard, D., and Kuchler, K. (1998) Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. Mol Biol Cell 9: 523-543.
12. Egner, R., Bauer, B.E., and Kuchler, K. (2000) The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. Mol Microbiol 35: 1255-1263.
13. Ernst, R., Klemm, R., Schmitt, L., and Kuchler, K. (2005) Yeast ATP-binding cassette transporters: cellular cleaning pumps. Methods Enzymol 400: 460-484.
14. Ernst, R., Kueppers, P., Stindt, J., Kuchler, K., and Schmitt, L. (2010) Multidrug efflux pumps: substrate selection in ATP-binding cassette multidrug efflux pumps - first come, first served? FEBS J 277: 540-549.
15. Eswar, N., Webb, B., Marti-Renom, M.A., Madhusudhan, M.S., Eramian, D., Shen, M.Y., etal. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5: Unit 5.6.
16. Fonzi, W.A., and Irwin, M.Y. (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
17. Golin, J., Ambudkar, S.V., Gottesman, M.M., Habib, A.D., Sczepanski, J., Ziccardi, W., and May, L. (2003) Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol Chem 278: 5963-5969.
18. Golin, J., Ambudkar, S.V., and May, L. (2007) The yeast Pdr5p multidrug transporter: how does it recognize so many substrates? Biochem Biophys Res Commun 356: 1-5.
19. Gupta, R.P., Kueppers, P., Schmitt, L., and Ernst, R. (2011) The multidrug transporter Pdr5: a molecular diode? Biol Chem 392: 53-60.
20. Hanson, L., May, L., Tuma, P., Keeven, J., Mehl, P., Ferenz, M., etal. (2005) The role of hydrogen bond acceptor groups in the interaction of substrates with Pdr5p, a major yeast drug transporter. Biochemistry 44: 9703-9713.
21. Hayama, K., Ishibashi, H., Ishijima, S.A., Niimi, K., Tansho, S., Ono, Y., etal. (2012) A d-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model. FEMS Microbiol Lett 328: 130-137.
22. Helmerhorst, E.J., Van't Hof, W., Veerman, E.C., Simoons-Smit, I., and Nieuw Amerongen, A.V. (1997) Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J 326: 39-45.
23. Hiraga, K., Wanigasekera, A., Sugi, H., Hamanaka, N., and Oda, K. (2001) A novel screening for inhibitors of a pleiotropic drug resistant pump, Pdr5, in Saccharomyces cerevisiae. Biosci Biotechnol Biochem 65: 1589-1595.
24. Holmes, A.R., Tsao, S., Ong, S.W., Lamping, E., Niimi, K., Monk, B.C., etal. (2006) Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol Microbiol 62: 170-186.
25. Holmes, A.R., Lin, Y.H., Niimi, K., Lamping, E., Keniya, M., Niimi, M., etal. (2008) ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 52: 3851-3862.
26. Kolaczkowski, M., van der Rest, M., Cybularz-Kolaczkowska, A., Soumillion, J., Konings, W.N., and Goffeau, A. (1996) Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem 271: 31543-31548.
27. Lamping, E., Monk, B.C., Niimi, K., Holmes, A.R., Tsao, S., Tanabe, K., etal. (2007) Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell 6: 1150-1165.
28. Lamping, E., Baret, P.V., Holmes, A.R., Monk, B.C., Goffeau, A., and Cannon, R.D. (2010) Fungal PDR transporters: phylogeny, topology, motifs and function. Fungal Genet Biol 47: 127-142.
29. Lee, M.D., Galazzo, J.L., Staley, A.L., Lee, J.C., Warren, M.S., Fuernkranz, H., etal. (2001) Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco 56: 81-85.
30. Lemoine, R.C., Glinka, T.W., Watkins, W.J., Cho, A., Yang, J., Iqbal, N., etal. (2004) Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp. Bioorg Med Chem Lett 14: 5127-5131.
31. Locher, K.P., Lee, A.T., and Rees, D.C. (2002) The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296: 1091-1098.
32. Maebashi, K., Niimi, M., Kudoh, M., Fischer, F.J., Makimura, K., Niimi, K., etal. (2001) Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J Antimicrob Chemother 47: 527-536.
33. Mishra, N.N., Prasad, T., Sharma, N., Lattif, A.A., Prasad, R., and Gupta, D.K. (2007) Membrane fluidity and lipid composition in clinical isolates of Candida albicans isolated from AIDS/HIV patients. Acta Microbiol Immunol Hung 54: 367-377.
34. Monk, B.C., Niimi, K., Lin, S., Knight, A., Kardos, T.B., Cannon, R.D., etal. (2005) Surface-active fungicidal d-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother 49: 57-70.
35. Nakamura, K., Niimi, M., Niimi, K., Holmes, A.R., Yates, J.E., Decottignies, A., etal. (2001) Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother 45: 3366-3374.
36. Niimi, K., Harding, D.R., Parshot, R., King, A., Lun, D.J., Decottignies, A., etal. (2004) Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a d-octapeptide derivative. Antimicrob Agents Chemother 48: 1256-1271.
37. Prasad, R., De Wergifosse, P., Goffeau, A., and Balzi, E. (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27: 320-329.
38. Puri, N., Gaur, M., Sharma, M., Shukla, S., Ambudkar, S.V., and Prasad, R. (2009) The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport. Biochim Biophys Acta 1788: 1752-1761.
39. Rutledge, R.M., Esser, L., Ma, J., and Xia, D. (2010) Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: a molecular modeling study. J Struct Biol 173: 333-344.
40. Sanglard, D., Ischer, F., Monod, M., and Bille, J. (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40: 2300-2305.
41. Sanglard, D., Ischer, F., Monod, M., and Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
42. Schuetzer-Muehlbauer, M., Willinger, B., Egner, R., Ecker, G., and Kuchler, K. (2003) Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 22: 291-300.
43. Shukla, S., Rai, V., Banerjee, D., and Prasad, R. (2006) Characterization of Cdr1p, a major multidrug efflux protein of Candida albicans: purified protein is amenable to intrinsic fluorescence analysis. Biochemistry 45: 2425-2435.
44. Tanabe, K., Lamping, E., Adachi, K., Takano, Y., Kawabata, K., Shizuri, Y., etal. (2007) Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium. Biochem Biophys Res Commun 364: 990-995.
45. Tanabe, K., Lamping, E., Nagi, M., Okawada, A., Holmes, A.R., Miyazaki, Y., etal. (2011) Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function. Mol Microbiol 82: 416-433.
46. Tsao, S., Rahkhoodaee, F., and Raymond, M. (2009) Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance. Antimicrob Agents Chemother 53: 1344-1352.
47. Wada, S., Niimi, M., Niimi, K., Holmes, A.R., Monk, B.C., Cannon, R.D., and Uehara, Y. (2002) Candida glabrata ATP-binding cassette transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties. J Biol Chem 277: 46809-46821.
48. Wada, S., Tanabe, K., Yamazaki, A., Niimi, M., Uehara, Y., Niimi, K., etal. (2005) Phosphorylation of Candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability. J Biol Chem 280: 94-103.
49. Watkins, W.J., Lemoine, R.C., Chong, L., Cho, A., Renau, T.E., Kuo, B., etal. (2004) Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives. Bioorg Med Chem Lett 14: 5133-5137.